BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24625108)

  • 1. Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.
    Sasabe N; Keyamura Y; Obama T; Inoue N; Masuko Y; Igarashi Y; Aiuchi T; Kato R; Yamaguchi T; Kuwata H; Iwamoto S; Miyazaki A; Hara S; Yoshikawa T; Itabe H
    Lipids Health Dis; 2014 Mar; 13():48. PubMed ID: 24625108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer and Enzyme-Mediated Metabolism of Oxidized Phosphatidylcholine and Lysophosphatidylcholine between Low- and High-Density Lipoproteins.
    Sawada N; Obama T; Mizuno M; Fukuhara K; Iwamoto S; Aiuchi T; Makiyama T; Itabe H
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
    Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
    Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
    Itabe H; Suzuki K; Tsukamoto Y; Komatsu R; Ueda M; Mori M; Higashi Y; Takano T
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):233-45. PubMed ID: 11018475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP; Pritchard PH
    J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids.
    Choi J; Zhang W; Gu X; Chen X; Hong L; Laird JM; Salomon RG
    Chem Res Toxicol; 2011 Jan; 24(1):111-8. PubMed ID: 20973507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
    Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
    Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
    Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
    Itabe H; Yamamoto H; Suzuki M; Kawai Y; Nakagawa Y; Suzuki A; Imanaka T; Takano T
    J Biol Chem; 1996 Dec; 271(52):33208-17. PubMed ID: 8969177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G; Zaręba M; Warpas A; Jamroz-Wiśniewska A; Rusek M; Czechowska G; Bełtowski J
    Eur J Pharmacol; 2019 May; 850():180-189. PubMed ID: 30768981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein.
    Davis B; Koster G; Douet LJ; Scigelova M; Woffendin G; Ward JM; Smith A; Humphries J; Burnand KG; Macphee CH; Postle AD
    J Biol Chem; 2008 Mar; 283(10):6428-37. PubMed ID: 18165686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
    Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
    J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
    Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human native, enzymatically modified and oxidized low density lipoproteins show different lipidomic pattern.
    Orsó E; Matysik S; Grandl M; Liebisch G; Schmitz G
    Biochim Biophys Acta; 2015 Mar; 1851(3):299-306. PubMed ID: 25583048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
    Tanaka T; Iimori M; Tsukatani H; Tokumura A
    Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
    Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.